期刊文献+

白细胞介素-6在2型糖尿病患者腹部皮下和网膜脂肪组织中的表达及其与胰岛素抵抗的关系 被引量:1

Expression of IL-6 in subcutaneous and omental adipose tissue of type 2 diabetes and their correlation with insulin resistance
原文传递
导出
摘要 目的探讨白细胞介素-6(IL-6)基因在2型糖尿病(T2DM)患者腹部皮下和网膜脂肪组织中的表达情况,及其与胰岛素抵抗的关系。方法用半定量RT-PCR方法检测22例正常人(对照组)和20例T2DM(糖尿病组)患者的大网膜与皮下脂肪组织IL-6 mRNA的表达水平,并测量体重、血压、腰围、臀围、血糖、空腹胰岛素、血脂和胰岛素敏感指数(IAI)。结果①糖尿病组网膜和皮下脂肪的IL-6 mRNA表达量均高于对照组(P<0.05);对照组网膜组织的IL-6 mRNA表达量高于皮下脂肪组织(P<0.05),而糖尿病组网膜和皮下脂肪组织差异无显著性(P>0.05)。②将两组数据合并,网膜和皮下脂肪的IL-6 mRNA表达量与腰臀比、胰岛素抵抗指数(HOMA-IR)呈正相关(P<0.05),与血浆IAI呈负相关(P<0.05),与其他因素均无相关性(均P>0.05)。③多元逐步回归分析发现,皮下脂肪IL-6 mRNA表达量与HOMA-IR、腰臀比相关(P<0.05),网膜IL-6 mRNA表达量与HOMA-IR相关(P<0.05)。结论T2DM患者网膜和皮下脂肪组织IL-6 mRNA表达水平升高,可以作为胰岛素抵抗的一个重要参数。 Objective To study the expression of interleukin-6 gene mRNA in subcutaneous and omental adipose tissue of type 2 diabetes mellitus paheat ( T2DM). Methods Semi-quantitative RT-PCR was used to detect the expression of interleukin-6 gene mRNA in omental and abdominal subcutaneous adipose tissue of 20 cases with T2DM and 22 case of non-diabetes controls. Results ( 1 ) The interleukin-6 mRNA expression in subcutaneous and omemal adipose tissue was significantly increased in patients with T2DM than that of non-diabetes controls ( P 〈 0.01 ). Compared with subcutaneous adipose tissue,the interleukin-6 mRNA expression in omental adipose tissue was significantly increased in non-diabetes controls ( P 〈 0.01 ), but that was not in patients with T2DM ( P 〉 0.05 ). ( 2 ) The expression level of IL-6 mRNA in all omental and abdominal subcutaneous adipose tissue were positively correlated with waist/hip ratio ( WHR ) and HOMA-IR ( P 〈 0.05 ), but was negatively with plasma IAI ( P 〈 0.05. ( 3 ) Muhi-stepwise regression analysis demonstrated that the expression level of IL-6 mRNA in abdominal subcutaneous adipose tissue was significantly correlated with HOMA-IR and WHR( P 〈 0.05 ) , and that the expression level of IL-6 mRNA in omental adipose tissue were correlated with HOMA-IR ( P 〈 0.05 ). Conclusion IL-6 mRNA expres- sions in subcutaneous and omental adipose tissue are significantly higher in cases with T2DM, which seems to be an important parameter of insulin resistance.
出处 《中国综合临床》 北大核心 2006年第10期880-883,共4页 Clinical Medicine of China
基金 安徽省自然科学基金资助项目(01043707 03043719)
关键词 2型糖尿病 白细胞介素-6 胰岛素抵抗 脂肪细胞 Type 2 diabetes mellitus Interleukin-6 Insulin resistance Adipose tissue
  • 相关文献

参考文献10

  • 1Kern PA, Ranganathan S, Li C, et al. Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance[J]. Am J Physiol Endocrinol Metab, 2001,280 ( 5 ) : 745-751.
  • 2Bastard JP,Maachi M,Van Nhieu JT,et al. Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro [ J ]. J Clin Endocrinol Metab, 2002,87(5) :2 084-2 089.
  • 3Pradhan AD, Manson JE, Rifai N, et al. C-reactive protein,interleukin 6, and risk of developing type 2 diabetes mellitus [ J ]. JAMA,2001,286 (3) :327-334.
  • 4Pickup JC, Chusney GD,Thomas SM, et al. Plasma intedeukin45,tumour necrosis factor alpha and blood cytokine production in type 2 diabetes[J]. Life Sci ,2000,67(3) :291-300.
  • 5Fried SK, Bunkin DA, Grecnberg AS, et al. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid [ J ]. J Clin Endocrinol Metab,1998,83(3) :847-850.
  • 6Rotter V, Nagaev I, Smith U,et al. Interleukin-6 (IL-6) induces insulin resistance in 3T3-L1 adipocytes and is, like IL-8 and tumor necrosis factor-alpha, overexpressed in human fat cells from insulinresistant subjects[J]. J Biol Chem,2003,278(46) :45 777-45 784.
  • 7Mohamed Ali V, Goodrick S, Rawesh A, et al. Subcutaneous adipose tissue releases interleukin-6,but not tumor necrosis factor-alpha,in vivo[J]. J Clin Endocrinol Metab,1997,82(12):4 196-4 200.
  • 8Bruun J M, Verdich C,Toubro S,et al. Association between measures of insulin sensitivity and circulating levels of interleukin-8,interleukin-6 and tumor necrosis factor-alpha. Effect of weight loss in obese men[J]. Eur J Endocrinol,2003,148 (5) :535-542.
  • 9Senn J J, Klover P J, Nowak IA, et al Interleukin-6 induces cellular insulin resistance in hepatocytes [ J ]. Diabetes, 2002, 51 ( 12 ) :3 391-3 399.
  • 10Fruhbeck G,Gomez Ambrosi J,Muruzabal FJ,et al. The adipocyte:a model for integration of endocrine and metabolic signaling in energy metabolism regulation [ J ]. Am J Physiol Endocrinol Metab, 2001,280(6) :827-847.

同被引文献6

  • 1朱旅云,刘坤申.血管内皮功能障碍对肥胖伴高血糖患者胰岛分泌功能的影响[J].中华糖尿病杂志(1006-6187),2004,12(5):348-351. 被引量:8
  • 2Nosadini R, Velussi M, Broceo E, et al. Altered transcapillary escape of albumin and microalbuminuria reflects two different pathogenetic mechanisms[ J]. Diabetes ,2005,54 ( 1 ) :228-233.
  • 3Arcaro G, Cretti A, Balzano S,et al. Insulin causes endothelial dysfunction in humans : sites and mechanisms [ J ]. Circulation, 2002, 105 (5) :576-582.
  • 4Benigni A, Gagliardini E, Tomasoni S, et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy[ J]. Kidney Int ,2004,65 (6) :2193-2200.
  • 5Ceol M, Gambaro G, Sauer U, et al. Glycosaminoglycan therapy prevents TGF-betal overexpression and pathologic changes in renal tissue of long - term diabetic rats [ J ]. J Am Soc Nephrol, 2000,11 (12) :2324-2336.
  • 6魏蓉,吴国亭.糖尿病的凝血与纤溶机制研究[J].同济大学学报(医学版),2003,24(4):295-297. 被引量:21

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部